Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.
Fiche publication
Date publication
août 2020
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRONOWICKI Jean-Pierre, Pr DI MARTINO Vincent, Pr HILLON Patrick, Dr JOUVE Jean-Louis, Dr MINELLO Anne, Pr PETIT Jean-Michel, Pr THIEFIN Gérard, Dr PAIS DE BARROS Jean-Paul, Dr COTTET Vanessa
Tous les auteurs :
Mouillot T, Rizk M, Pais de Barros JP, Gilloteau A, Busson A, Bernard-Chabert B, Thiefin G, Barraud H, Bronowicki JP, Richou C, Di Martino V, Doffoel M, Minello A, Latournerie M, Jouve JL, Brondel L, Brindisi MC, Petit JM, Hillon P, Cottet V,
Lien Pubmed
Résumé
Disturbances in fatty acid (FA) metabolism have been reported in cirrhosis, but the role of FAs in the development of hepatocellular carcinoma (HCC) is still unclear. Biomarkers are a promising means to explore the associations between exogenous intake or endogenous production of FAs and cancer risk.
Référence
Aliment. Pharmacol. Ther.. 2020 Aug 11;: